Is metformin the treatment of choice for anovulation in polycystic ovary syndrome?

被引：12
|
作者：
Balen, Adam H. [1 ]
机构：
[1] Leeds Gen Infirm, Reprod Med Unit, Leeds LS2 9NS, W Yorkshire, England
来源：
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 2007年 / 3卷 / 06期
关键词：
D O I：
10.1038/ncpendmet0511
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The insulin-sensitizing agent metformin has been heralded as a novel therapy for women with polycystic ovary syndrome-associated anovulatory infertility. The author of this Viewpoint reviews the evidence from clinical trials and asks whether metformin will become the first-line therapy for ovulation induction in polycystic ovary syndrome.
引用
收藏
页码：440 / 441
页数：2
相关论文
共 50 条
  • [41] Use of metformin in polycystic ovary syndrome
    Koch, YD
    Ernst, ME
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1644 - 1647
  • [42] Metformin therapy in polycystic ovary syndrome
    Jakimiuk, Artur J.
    GINEKOLOGIA POLSKA, 2008, 79 (01) : 8 - 11
  • [43] Metformin and intervention in polycystic ovary syndrome
    Norman, RJ
    Kidson, WJ
    Cuneo, RC
    Zacharin, MR
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (11) : 580 - +
  • [44] Reimbursement of metformin for polycystic ovary syndrome
    Milewicz, Andrzej
    ENDOKRYNOLOGIA POLSKA, 2013, 64 (05) : 409 - 414
  • [45] Use of metformin in polycystic ovary syndrome
    Mathur, Ruchi
    Alexander, Carolyn J.
    Yano, Jacqueline
    Trivax, Bradley
    Azziz, Ricardo
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (06) : 596 - 609
  • [46] Polycystic ovary syndrome and metformin in pregnancy
    Lilja, Anna E.
    Mathiesen, Elisabeth R.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2006, 85 (07) : 861 - 868
  • [47] Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome
    Zhang, Chuyue
    Ma, Jin
    Wang, Wangsheng
    Sun, Yun
    Sun, Kang
    HUMAN REPRODUCTION, 2018, 33 (11) : 2096 - 2106
  • [48] Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome
    Raperport, Claudia
    Chronopoulou, Elpiniki
    Homburg, Roy
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2021, 16 (02) : 37 - 47
  • [49] Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
    Diri, Halit
    Karaburgu, Sulbiye
    Acmaz, Banu
    Unluhizarci, Kursad
    Tanriverdi, Fatih
    Karaca, Zuleyha
    Kelestimur, Fahrettin
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (01) : 42 - 45
  • [50] The role of metformin in the management of polycystic ovary syndrome
    Tsilchorozidou, T
    Prelevic, GM
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2003, 15 (06) : 483 - 488
12345